Literature DB >> 14747185

A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia-effect on FSH levels and menopausal symptoms.

K Halmesmäki1, R Hurskainen, A Tiitinen, J Teperi, S Grenman, A Kivelä, E Kujansuu, M Yliskoski, J Paavonen.   

Abstract

BACKGROUND: The purpose of this study was to compare the effects of hysterectomy and a levonorgestrel-releasing intrauterine system (LNG-IUS) on serum FSH levels and menopausal symptoms.
METHODS: A total of 236 women referred for menorrhagia to five university hospitals were randomly assigned to treatment with hysterectomy (n = 117) or LNG-IUS (n = 119). Menopausal symptoms were characterized by the Kupperman menopausal distress test. Serum FSH and estradiol levels were measured at baseline and 6 and 12 months after hysterectomy or application of LNG-IUS. Analyses were by intention to treat.
RESULTS: After 6 months, there was no difference between the groups, but 12 months after follow-up hysterectomized women had higher FSH levels than women with LNG-IUS (P = 0.005). There was a significant association between FSH levels and treatment modality (P = 0.020). Hot flushes increased significantly in the hysterectomy group (P = 0.02). There was a significant association between hot flushes and both treatment modality and age (P = 0.02 and P = 0.01, respectively).
CONCLUSION: Hysterectomy may impair ovarian function shown by rising serum FSH levels and hot flushes. However, these results should be interpreted with caution, and longer follow-up is needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747185     DOI: 10.1093/humrep/deh055

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

Review 1.  The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.

Authors:  Andrew M Kaunitz; Pirjo Inki
Journal:  Drugs       Date:  2012-01-22       Impact factor: 9.546

2.  Osteoporosis in a young woman after 6 years of levonorgestrel administration from intrauterine devices?

Authors:  Christine Ursula Greiner; Kay Brune; Ekkehard Haen
Journal:  BMJ Case Rep       Date:  2009-03-05

Review 3.  Surgery versus medical therapy for heavy menstrual bleeding.

Authors:  Jane Marjoribanks; Anne Lethaby; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2016-01-29

Review 4.  Contraception During Perimenopause: Practical Guidance.

Authors:  Giovanni Grandi; Pierluigi Di Vinci; Alice Sgandurra; Lia Feliciello; Francesca Monari; Fabio Facchinetti
Journal:  Int J Womens Health       Date:  2022-07-15

5.  Dose-Dependent Effects of the Cimicifuga racemosa Extract Ze 450 in the Treatment of Climacteric Complaints: A Randomized, Placebo-Controlled Study.

Authors:  Ruediger Schellenberg; Reinhard Saller; Lorenzo Hess; Jörg Melzer; Christian Zimmermann; Juergen Drewe; Catherine Zahner
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-23       Impact factor: 2.629

6.  Progestogen-releasing intrauterine systems for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Vanessa Jordan
Journal:  Cochrane Database Syst Rev       Date:  2020-06-12

Review 7.  Management of endometrial modifications in perimenopausal women.

Authors:  Renata Nicula; Nicolae Costin
Journal:  Clujul Med       Date:  2015-04-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.